leadf
logo-loader
viewAIBIOS

AIBIOS using quantum computing platform to investigate anti-inflammatory diseases

AIBIOS Inc CEO Akio Sato sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Japan-based company is investigating the anti-inflammatory benefits of synthesized compounds using a quantum computing platform.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Itaconix reports 'dramatic turnaround for the direction of the company'

Itaconix PLC's (LON:ITX, OTCQB: ITXXF) John Shaw talks to Proactive London's Katie Pilbeam about their 2019 results which revealed sales rose 46% to $1.3mln, while gross profits were up 221% to $450,000. Shaw notes how despite their 'tremendous pipeline' revenues for the end of last year were...

3 hours, 22 minutes ago

2 min read